Refine by
Genomics And Proteomics Articles & Analysis
19 news found
By integrating data from multiple sources, including genomics and proteomics, their AI models can identify unexplored targets, potentially accelerating the development of novel therapeutics. ...
CD BioGlyco, a biotechnology company that provides multi-omics analysis of cancer cell glycolysis including genomics, proteomics, metabolomics and metabolic fluxomics, now offers analysis of glycolytic enzymes in cancer cells, enabling thorough understanding of cancer cell glycolysis pathways. ...
They enable the true on/off-target mutations of genome editing experimentation to be determined in conjunction with genome-wide off-target detection systems (GUIDE-seq, WGS) at high sensitivity and in a non-biased way. ...
Fairly recently, the company launched a series of structure-based drug design (SBDD) services, showing capabilities in virtual screening, flexible target sampling, skeleton transitions, de novo design, and more. The abundance of studies on genomics and proteomics presents hundreds of new targets and opportunities for drug discovery attempts. ...
The Bioinformatics-Analysis, a subdivision of CD Genomics, provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. CD Genomics provides metatranscriptome sequencing data analysis service using bioinformatics analysis ...
CD Genomics recently launched various types of genotyping analysis services, including analysis of data generated by different classification techniques, such as whole-genome sequencing, whole-exome sequencing, whole-genome SNP chips, and mass spectrometry. ...
Date: Thursday, February 3, 2022 Time: 2pm ET / 11am PT Duration: 1 Hour Sign up here to go to the webinar Improving the discovery of novel drugs with artificial intelligence Last year, Toronto-based Deep Genomics used artificial intelligence to scan 200,000 genomes from people with a variety of diseases, and in so doing identified a disease ...
Want more detailed information about it? Please get in touch with CD Genomics at (631) 259-7705 or send an email to contact@cd-genomics.com. Scientists here would be more than happy to serve you. About CD Genomics CD Genomics is one of the reliable providers of bioinformatics analysis services, with a high-performance computing platform and a ...
DNA methylation is established and maintained by DNA methyltransferases (DNMT1, DNMT3a, and DNMT3b). CD Genomics uses a mature high-throughput sequencing platform combined with epigenetics to provide a variety of biological information analysis services such as genome-wide epigenetic location analysis and gene expression regulation mechanism research. ...
The platform is a leading open solution for data-driven innovation, which aims to discover hidden potential in biological data and unearth new insights or predict new prospects related to life science research. CD Genomics provides Targeted Proteomics Analysis service from project design, data analysis to chart making, combined with its efficient ...
In addition, the company offers services for the life sciences, including genomics, proteomics, and cell analyses. “With MH Guide, doctors can manage the flood of data from molecular genetic testing and translate it into targeted therapy recommendations. ...
Several biomarker candidates have been identified in urine, in the field of genomics, transcriptomics, proteomics, and metabolomics. However, collecting a urine sample with a standard urine cup can be awkward, messy and inconvenient for the patient. ...
Academic and industrial researchers working with and developing bioassays for a wide range of analytes Scientists specializing or have expertise in the following fields: biomedical and clinical science, proteomics, genomics, biochemistry, nanotechnology and biophysics Presenter Dr. ...
Academic and industrial researchers working with and developing bioassays for a wide range of analytes Scientists specializing or have expertise in the following fields: biomedical and clinical science, proteomics, genomics, biochemistry, nanotechnology and biophysics Presenter Dr. ...
They are using a combination of genomic and proteomic technologies from Agilent to characterize tumor-initiating cells with stem-cell-like properties derived from solid tumors taken from subjects with various types of cancer. ...
The first grant, for "Validating Protein Pathway Information: Integrating Proteomic Data with Transcriptomic or Metabolomic Data Sets," was awarded to MacCoss, an assistant professor in the department of genome sciences at the University of Washington. ...
NIEHS researchers continue to learn more about genetic susceptibility to asthma, by working closely with other NIH-funded researchers and international collaborators to conduct genome-wide association studies. The studies are aimed at identifying genetic risk factors and their interactions with environmental risk factors, in order to characterize how they may influence ...
NIEHS researchers continue to learn more about genetic susceptibility to asthma, by working closely with other NIH-funded researchers and international collaborators to conduct genome-wide association studies. The studies are aimed at identifying genetic risk factors and their interactions with environmental risk factors, in order to characterize how they may influence ...
Precision's state of the art bioinformatics combined with the analysis of the live molecular, proteomic and genomic activity of each patient's cancer offers an innovative foundation for further development and commercialization of novel predictive markers for cancer therapy. ...